Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33,235,472
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
23,932,784
-
Shares change
-
+2,942,019
-
Total reported value, excl. options
-
$294,127,661
-
Value change
-
+$42,108,506
-
Put/Call ratio
-
17%
-
Number of buys
-
60
-
Number of sells
-
20
-
Price
-
$12.29
Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q1 2025
As of 31 Mar 2025 NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,932,784 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Soleus Capital Management, L.P., MORGAN STANLEY, First Light Asset Management, LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, Kent Lake PR LLC, DEUTSCHE BANK AG\, and BlackRock, Inc..
This table shows 89 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.